Urinary angiotensinogen in pediatric urinary tract infection

Pediatr Int. 2019 Jul;61(7):712-714. doi: 10.1111/ped.13890. Epub 2019 Jul 23.

Abstract

Background: Urinary tract infection (UTI) is one of the most common diseases in children, and urinary angiotensinogen (U-AGT) is a new biomarker gathering attention in many renal diseases. U-AGT reflects intrarenal renin-angiotensin system (RAS) activity. We conducted a study to measure U-AGT in children <4 months old with UTI.

Methods: All children <4 months old who came to Toshima Hospital with fever between January 2015 and December 2015 were included. Patients were divided into a UTI group and a non-UTI group, and U-AGT was measured.

Results: Median U-AGT was higher in patients with UTI compared with patients without UTI: (0.56 ng/dL, range, 0.025-2.753 ng/dL vs 0.13 ng/dL, range, 0.008-1.697 ng/dL, respectively; P < 0.05).

Conclusions: U-AGT is elevated in UTI patients, and RAS activation may contribute to renal injury caused by UTI.

Keywords: angiotensinogen; renal scarring; renin-angiotensin system; urinary angiotensinogen; urinary tract infection.

Publication types

  • Clinical Trial

MeSH terms

  • Angiotensinogen / urine*
  • Biomarkers / urine
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Prospective Studies
  • Urinary Tract Infections / diagnosis*
  • Urinary Tract Infections / urine

Substances

  • AGT protein, human
  • Biomarkers
  • Angiotensinogen